Dubiotech Bets On ''If You Build It, They Will Come,'' Despite Funding Shortages
This article was originally published in PharmAsia News
Executive Summary
Dubai-based biotech research park Dubiotech unveiled plans for what it is calling a "state-of-art nucleotide laboratory complex," hoping it will draw multinational tenants to the Middle East in force